Correlation Between Summit Materials and COSCIENS Biopharma

Can any of the company-specific risk be diversified away by investing in both Summit Materials and COSCIENS Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Summit Materials and COSCIENS Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Summit Materials and COSCIENS Biopharma, you can compare the effects of market volatilities on Summit Materials and COSCIENS Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Summit Materials with a short position of COSCIENS Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Summit Materials and COSCIENS Biopharma.

Diversification Opportunities for Summit Materials and COSCIENS Biopharma

-0.85

Correlation Coefficient

Summit Materials  COSCIENS Biopharma

Pay attention - limited upside

The 3 months correlation between Summit and COSCIENS is -0.85. Overlapping area represents the amount of risk that can be diversified away by holding Summit Materials and COSCIENS Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on COSCIENS Biopharma and Summit Materials is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Summit Materials are associated (or correlated) with COSCIENS Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of COSCIENS Biopharma has no effect on the direction of Summit Materials i.e., Summit Materials and COSCIENS Biopharma go up and down completely randomly.

Pair Corralation between Summit Materials and COSCIENS Biopharma

Considering the 90-day investment horizon Summit Materials is expected to generate 0.48 times more return on investment than COSCIENS Biopharma. However, Summit Materials is 2.09 times less risky than COSCIENS Biopharma. It trades about 0.07 of its potential returns per unit of risk. COSCIENS Biopharma is currently generating about -0.05 per unit of risk. If you would invest  2,865  in Summit Materials on September 21, 2024 and sell it today you would earn a total of  2,170  from holding Summit Materials or generate 75.74% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Summit Materials  vs.  COSCIENS Biopharma

Summit Materials

Risk-Adjusted Performance

17 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Summit Materials are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Summit Materials displayed solid returns over the last few months and may actually be approaching a breakup point.

COSCIENS Biopharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days COSCIENS Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in January 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Pair Trading with Summit Materials and COSCIENS Biopharma

The main advantage of trading using opposite Summit Materials and COSCIENS Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Summit Materials position performs unexpectedly, COSCIENS Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in COSCIENS Biopharma will offset losses from the drop in COSCIENS Biopharma's long position.

The idea behind Summit Materials and COSCIENS Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.